查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886284

乳房切片器材市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、手術方式、應用、最終用戶、地區和競爭格局分類，2020-2030年預測

Breast Biopsy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Procedure, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球乳房切片器材市場規模為10.2億美元，預計2030年將以6.89%的複合年成長率成長至15.2億美元。乳房切片器械是用於從可疑乳房病灶中提取組織樣本以進行確診檢查的專用儀器，涵蓋了各種基於針頭和真空輔助的系統，並可在影像引導下進行操作。全球乳房切片器材市場的主要促進因素是乳癌發生率的上升、大眾對早期檢測意識的增強以及對微創診斷程序的日益青睞。

市場概覽
預測期 2026-2030
市場規模：2024年 10.2億美元
市場規模：2030年 15.2億美元
複合年成長率：2025-2030年 6.89%
成長最快的細分市場 切片針
最大的市場 北美洲

主要市場促進因素

全球乳房切片設備市場受到全球乳癌發生率不斷上升的顯著影響，這導致對有效診斷解決方案的需求持續且迫切。發病率的上升使得更頻繁、更準確的活體組織切片成為必要，以確診並指導治療策略。

主要市場挑戰

先進的活體組織切片手術費用高昂，且依賴昂貴的影像技術，這嚴重阻礙了全球乳房活體組織切片設備市場的成長。這一經濟障礙直接限制了市場擴張，限制了這些重要診斷工具的普及，尤其是在資源匱乏地區和預算緊張的醫療體系中。

主要市場趨勢

將人工智慧和機器學習技術整合到乳房活體組織切片設備中，正在改變市場上的診斷準確性和工作流程效率。這些先進的計算方法增強了影像分析能力，幫助放射科醫生更精確地識別細微異常並區分良性和惡性病變。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球乳房切片設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（切片針、導引系統、切片台、定位導線、檢測試劑盒、液體切片儀器、其他）
    • 依操作方法（針刺乳房切片、開放式手術乳房切片、液體乳房切片檢查）
    • 按應用領域（早期癌症篩檢、治療方案選擇、治療監測、復發監測）
    • 按最終使用者（醫院和手術中心、乳房護理中心、影像診所和診斷中心）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美乳房切片設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲乳房切片設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區乳房切片設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲乳房切片設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲乳房切片設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球乳房切片設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Hologic Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Argon Medical Devices, Inc.
  • Guardant Health, Inc.
  • Merit Medical Systems, Inc.
  • Neogenomics Laboratories, Inc.
  • Sysmex Inostics, Inc.
  • Sterylab SRL
  • Bio-Rad Laboratories Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22203

The Global Breast Biopsy Devices Market, valued at USD 1.02 Billion in 2024, is projected to experience a CAGR of 6.89% to reach USD 1.52 Billion by 2030. Breast biopsy devices are specialized instruments utilized to extract tissue samples from suspicious breast lesions for definitive diagnostic examination, encompassing various needle-based and vacuum-assisted systems guided by imaging modalities. The global market for these devices is primarily driven by the increasing incidence of breast cancer, growing public awareness regarding early detection, and the expanding preference for minimally invasive diagnostic procedures.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.02 Billion
Market Size 2030USD 1.52 Billion
CAGR 2025-20306.89%
Fastest Growing SegmentBiopsy Needles
Largest MarketNorth America

Key Market Drivers

The global breast biopsy devices market is significantly influenced by the increasing worldwide prevalence of breast cancer, creating a sustained and urgent demand for effective diagnostic solutions. The rising incidence necessitates more frequent and accurate biopsies to confirm diagnoses and guide treatment strategies. According to the World Cancer Research Fund, in 2022, there were 2,296,840 new cases of breast cancer among women globally, underscoring the critical need for advanced diagnostic tools.

Key Market Challenges

The substantial cost associated with advanced biopsy procedures and their reliance on expensive imaging modalities represents a significant impediment to the growth of the Global Breast Biopsy Devices Market. This financial barrier directly restricts market expansion by limiting the adoption of these essential diagnostic tools, particularly within resource-limited regions and healthcare systems operating under stringent budgetary constraints. The high capital investment required for state-of-the-art imaging equipment, such as specialized mammography units or MRI systems, coupled with the ongoing expenses for maintenance and skilled personnel, renders these advanced diagnostic pathways largely inaccessible to a significant portion of the global healthcare infrastructure.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning into breast biopsy devices is transforming diagnostic accuracy and workflow efficiency within the market. These advanced computational methods enhance image analysis, aiding radiologists in identifying subtle anomalies and differentiating between benign and malignant lesions with greater precision. According to a EuroAIM/EuSoMII 2024 survey among members of the European Society of Radiology, 48% of respondents were already utilizing AI or planning its adoption, with a predominant expected impact on breast imaging. This widespread acceptance underscores the growing confidence in AI's capabilities.

Key Market Players

  • Hologic Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Argon Medical Devices, Inc.
  • Guardant Health, Inc.
  • Merit Medical Systems, Inc.
  • Neogenomics Laboratories, Inc.
  • Sysmex Inostics, Inc.
  • Sterylab S.R.L.
  • Bio-Rad Laboratories Inc.

Report Scope:

In this report, the Global Breast Biopsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Biopsy Devices Market, By Type:

  • Biopsy Needles
  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Assay Kits
  • Liquid Biopsy Instruments
  • Others

Breast Biopsy Devices Market, By Procedure:

  • Needle Breast Biopsy
  • Open Surgical Breast Biopsy
  • Liquid Breast Biopsy

Breast Biopsy Devices Market, By Application:

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring

Breast Biopsy Devices Market, By End User:

  • Hospitals & Surgical Centers
  • Breast Care Centers
  • Imaging Clinics & Diagnostic Centers

Breast Biopsy Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Breast Biopsy Devices Market.

Available Customizations:

Global Breast Biopsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Breast Biopsy Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others)
    • 5.2.2. By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy)
    • 5.2.3. By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring)
    • 5.2.4. By End User (Hospitals & Surgical Centers, Breast Care Centers, Imaging Clinics & Diagnostic Centers)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Breast Biopsy Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Procedure
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Breast Biopsy Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Procedure
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Breast Biopsy Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Procedure
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Breast Biopsy Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Procedure
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Breast Biopsy Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Procedure
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Breast Biopsy Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Procedure
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Breast Biopsy Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Procedure
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Breast Biopsy Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Procedure
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Breast Biopsy Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Procedure
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Breast Biopsy Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Procedure
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Breast Biopsy Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Procedure
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Breast Biopsy Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Procedure
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Breast Biopsy Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Procedure
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Breast Biopsy Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Procedure
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Breast Biopsy Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Procedure
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Breast Biopsy Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Procedure
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Breast Biopsy Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Procedure
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Breast Biopsy Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Procedure
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Breast Biopsy Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Procedure
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Breast Biopsy Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Procedure
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Breast Biopsy Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Procedure
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Breast Biopsy Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Procedure
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Breast Biopsy Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Procedure
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Breast Biopsy Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Procedure
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Breast Biopsy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hologic Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Danaher Corporation
  • 15.3. Becton, Dickinson and Company
  • 15.4. Argon Medical Devices, Inc.
  • 15.5. Guardant Health, Inc.
  • 15.6. Merit Medical Systems, Inc.
  • 15.7. Neogenomics Laboratories, Inc.
  • 15.8. Sysmex Inostics, Inc.
  • 15.9. Sterylab S.R.L.
  • 15.10. Bio-Rad Laboratories Inc.

16. Strategic Recommendations

17. About Us & Disclaimer